stock.name

Enzon Pharmaceuticals Inc

ENZN

Market Cap$5.94M
Close$

Compare Enzon Pharmaceuticals

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Enzon Pharmaceuticals IncEnzon Pharmaceuticals Inc-24.60%-1%--
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9

Share Statistics

Market cap$5.94 Million
Enterprise Value$-40,619,832.00
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.0
Beta0.0
Outstanding Shares74,214,603
Avg 30 Day Volume41,119

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-24.64
PEG40.03
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-1562.3
Enterprise Value to EBIT39.1
Enterprise Value to Net Income168
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Enzon Pharmaceuticals Inc

CEO: Andrew Rackear

Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the ...